Skip to main
DERM

DERM Earnings Dates & Reports

DERM Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.08
Actual EPS-$0.08
EarningsMeet

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

DERM Earnings per Share (EPS) History

Signup for full access
Browse free

DERM Latest Earnings

The value each DERM share was expected to gain vs. the value each share gained.

DERM reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.08. This exceeded analysts' expectations of -$0.08 by 0.00%, marking a Meet.

For comparison, Journey Medical Corp reported EPS of -$0.18 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.02.

DERM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.02
Q1 2026
-$0.08-$0.080.00%
Q4 2025
-$0.05-$0.04-20.00%
Q3 2025
-$0.05-$0.09+80.00%
Q2 2025
-$0.07-$0.16+128.57%
View all

DERM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Journey Medical Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

DERM Earnings FAQs

DERM last reported earnings on May 13, 2026 for Q1 2026, posting an EPS of -$0.08, which Meet the estimate of -$0.08 by 0.00%.

For Q1 2026, DERM reported an EPS of -$0.08, missing analysts' estimate of -$0.08 by 0.00%.

For Q1 2026, DERM Meet expectations with an actual EPS of -$0.08 vs. an estimated EPS of -$0.08.

Following the last earnings report on May 13, 2026, DERM's stock price moved — from — to —.

The next DERM earnings call is scheduled for Aug. 11, 2026, where executives will discuss financial results and outlook.

Journey Medical Corp (DERM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.